Literature DB >> 19747012

Prothrombin complex concentrate (Beriplex P/N).

Lesley J Scott1.   

Abstract

Beriplex P/N, a prothrombin complex concentrate derived from pooled human plasma, contains the vitamin K-dependent coagulation factors II, VII, IX and X, and the vitamin K-dependent coagulation inhibition proteins C and S. Intravenous Beriplex P/N provided rapid and sustained normalization of elevated international normalized ratios and controlled bleeding in adult patients participating in several prospective, noncomparative clinical studies (n = 8-43), with these data supported by clinical experience during its use over more than a decade. Based on extensive clinical experience, Beriplex P/N is also effective in the treatment of congenital deficiency of any of the vitamin K-dependent coagulation factors when purified specific coagulation factor products are not available. Over a decade of clinical experience and more limited data from clinical studies have shown that intravenous infusions of Beriplex P/N were generally well tolerated in adult patients with acquired or congenital deficiencies of the vitamin K-dependent coagulation factors. To date, there have been no proven cases of viral transmission reported in any published studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747012     DOI: 10.2165/11203690-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

Review 1.  American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

Authors:  Jack Hirsh; Valentin Fuster; Jack Ansell; Jonathan L Halperin
Journal:  Circulation       Date:  2003-04-01       Impact factor: 29.690

2.  Guidelines on oral anticoagulation (warfarin): third edition--2005 update.

Authors:  T P Baglin; D M Keeling; H G Watson
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

3.  Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data?

Authors:  C M Kessler
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients.

Authors:  F E Preston; S T Laidlaw; B Sampson; S Kitchen
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

5.  Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee.

Authors:  Thorsten Steiner; Markku Kaste; Markku Katse; Michael Forsting; David Mendelow; Hubert Kwiecinski; Istvan Szikora; Seppo Juvela; Andrzej Marchel; René Chapot; Christophe Cognard; Andreas Unterberg; Werner Hacke
Journal:  Cerebrovasc Dis       Date:  2006-07-28       Impact factor: 2.762

6.  Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage.

Authors:  Bernard Vigué; Catherine Ract; Benjamin Tremey; Nicolas Engrand; Pierre Etienne Leblanc; Anne Decaux; Laurent Martin; Dan Benhamou
Journal:  Intensive Care Med       Date:  2007-01-27       Impact factor: 17.440

7.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

Review 8.  Warfarin and intracranial haemorrhage.

Authors:  Rebecca Appelboam; Elfyn O Thomas
Journal:  Blood Rev       Date:  2008-06-25       Impact factor: 8.250

Review 9.  Current management of acquired factor VIII inhibitors.

Authors:  Brian Barnett; Rebecca Kruse-Jarres; Cindy A Leissinger
Journal:  Curr Opin Hematol       Date:  2008-09       Impact factor: 3.284

Review 10.  Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice.

Authors:  Bernard Vigué
Journal:  Crit Care       Date:  2009-04-22       Impact factor: 9.097

View more
  5 in total

Review 1.  Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis.

Authors:  Linan Zeng; Imti Choonara; Lingli Zhang; Youping Li; Jing Shi
Journal:  Eur J Pediatr       Date:  2017-03-09       Impact factor: 3.183

2.  Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.

Authors:  Klaus Görlinger; Dietmar Fries; Daniel Dirkmann; Christian F Weber; Alexander A Hanke; Herbert Schöchl
Journal:  Transfus Med Hemother       Date:  2012-03-08       Impact factor: 3.747

3.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690

4.  The epidemic of pre-injury oral antiplatelet and anticoagulant use.

Authors:  A E Berndtson; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-05-01       Impact factor: 3.693

5.  Spontaneous spinal epidural hematoma in a patient with acquired Factor X deficiency secondary to systemic amyloid light-chain amyloidosis.

Authors:  Hidetaka Arishima; Ayumi Tada; Makoto Isozaki; Ryuhei Kitai; Toshiaki Kodera; Ken-ichiro Kikuta; Katsunori Tai; Hiromichi Iwasaki
Journal:  J Spinal Cord Med       Date:  2014-06-29       Impact factor: 1.985

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.